Drug intelligence / Profile preview

trenbolone hexahydrobenzylcarbonate

Development stage
Unknown
Lead developer
Alpha-Pharma Healthcare
Modality
Small Molecules
Administration
Intramuscular
01

Overview

Parabolin is a long-acting injectable anabolic-androgenic steroid (AAS) containing trenbolone hexahydrobenzylcarbonate, a synthetic derivative of nandrolone. Developed to provide a slow release of the active hormone trenbolone into the bloodstream, it is characterized by its potent anabolic effects and significant androgenic activity. Trenbolone works by binding to and activating the androgen receptor, which enhances protein synthesis, nitrogen retention in muscles, and the production of insulin-like growth factor-1 (IGF-1). Unlike many other testosterone derivatives, trenbolone does not undergo aromatization to estrogen, making it highly valued in clinical and performance contexts for promoting lean muscle mass and strength without significant water retention. While historically used for treating conditions such as muscle wasting, malnutrition, and osteoporosis, its use is now primarily associated with specialized pharmaceutical markets and veterinary applications.

Brand names
ParabolinParabolan
Other names
Trenbolone cyclohexylmethylcarbonateHexabolan
02

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on trenbolone hexahydrobenzylcarbonate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on trenbolone hexahydrobenzylcarbonate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call